Skip to main content
OpenTrials
Completed

NCT Number: NCT01713504

Identification of New Markers in the Hypereosinophilic Syndrome

The purpose is to characterize new hypereosinophilic syndrome biomarkers more informative and more accessible compared to those that we have already thanks to a proteomic approach. This will help the investigators to diagnose the this disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypereosinophilic Syndrome Eosinophilia Hematologic Diseases Hemic and Lymphatic Diseases Leukocyte Disorders

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHRU, Hôpital Claude Huriez

Lille, Nord, 59037, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • dated and signed informed consent
  • virale serology negative or negative result less than 6 months
  • virale serology negative for HBV or vaccinated patient
  • insured
  • virale serology negative or negative result less than 6 months
  • negative pregnancy test or female menopause for at least 1 year

Exclusion criteria

  • subject enable adult, under guardianship or under protective measures of justice
  • Refusal or inability to give informed consent
  • The hypereosinophilic syndrome explained origin other than than atopy, bullous pemphigoid, the Churg-Strauss syndrome and DRESS

Treatment and study plan

biologie sample

Biological

comparison of biomarkers between HES, HE biomarkers data and control arms

Primary outcomes

  1. The aim is to characterize, through an approach immunoprotéomique, new HES biomarkers more informative and easier access than those currently available to us. These biomarkers will help to the diagnosis of HES, compared with other causes of eosinophilia.

    Time frame: one month after patient inclusion

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Registry information

Acronym: SHE

Important dates

Study start
2010
Primary completion
2015
Study completion
2015
First posted
Oct 24, 2012
Registry last updated
Jan 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.